Building a Retail Empire – One Store at a Time!
There is never a dull day in the Cannabis Industry!
Each day brings news of consolidations, expansions and diversification of established as well new entrants...
Positive Interim Results from Clinical Trial Offers Hope to Patients with...
Earlier this year, we had covered some path-breaking companies engaged in clinical trials, to test the efficacy and safety of novel therapeutics, which could...
A Potential Disruptor In The Micro-Endoscopic Device Market
Medigus Ltd, (NASDAQ:MDGS) a pioneer in developing cutting-edge minimally invasive surgical tools and imaging solutions for medical as well as industrial use, announced that...
Targeted Immunotherapy – Revigorating The Treatment Of Prostate Cancer
Prostate Cancer is the second leading cause of death in men in the U.S, with over 1 in 41 men likely to succumb to...
Maxar Technologies – Stock took a beating despite of positive news,...
Shares of Maxar Technologies (NYSE: MAXR) rose by almost 28% on May 23, before plunging 10%, summing up what turned out to be a rollercoaster...
The Augmented Reality Company is on a roll with Major Deals...
Imagination Park Technologies Inc. (CSE: IP) (OTCQB: IPNFF), an augmented reality (AR) platform, announced that it has acquired XenoHolographic. The transaction involved the transfer of...
Breaking New Ground with HEXWAVE, a potential Game Changer in Weapon...
Liberty Defense Holdings (OTCPK: LDDFF), a pioneer in security solutions dealing with detection of concealed weapons in areas with high volume foot traffic, has...
Initiates Make-or-Break Phase 3 Clinical Trials in AngelMan Syndrome
Ovid Therapeutics (NASDAQ: OVID), a biopharmaceutical company developing novel therapeutics for rare neurological disorders, announced the launch of a crucial phase 3 clinical trial...
GrowLife – Bringing Innovation to the Cannabis Cultivation Space!
GrowLife, Inc (OTCPK: PHOT), a pioneer in the cultivation equipment provider space, announced an agreement with Emerald Metrics, LLC, an award-winning cannabis technology provider,...
Will LIBRA Create A Financial Utopia or Dystopia?
People around the word may be separated by geographical boundaries, ethnicities and religion but one thing that unites them all is FACEBOOK!
Facebook is ubiquitous,...
Parcel Pal Technologies – On the Quick Road to Success
ParcelPal Technologies (CNSX: PKG) (OTCPK: PTNYF), a Canadian on-demand local delivery service provider, announced the completion of a major milestone of delivering over 2,500,000...
Fair Prospects ahead for Sirona Biochem with Grant of Key Patent...
Sirona Biochem (OTCPK: SRBCF), a biopharmaceutical company focused on discovering novel cosmetic and pharmaceutical compounds, announced the grant of a patent for TFC-1067, its...
Gene Therapy offers Cure for Bubble Boy Syndrome
Severe combined immunodeficiency (SCID) or “Bubble Boy Syndrome” is a rare genetic disorder caused by gene mutations that inhibit the functioning of immune cells....
ReWalk Raises $5M for its ReStore Exosuit for Stroke Victims
Standing Tall
ReWalk Robotics (NASDAQ: RWLK) recently received an approval for its ReStore exoskeleton system, indicated for rehabilitation of stroke victims, from the FDA. The company...
The Emerging Paradigm in HIV Therapeutics Offers Hope for a Cure
Human Immunodeficiency Virus (HIV) compromises the body’s immunity by attacking CD4 cells (a type of T cell), exposing it to a host of infections...
Obalon Granted First US Patent for its Proprietary Intragastric Balloon System.
Obalon Therapeutics (NASDAQ: OBLN), the manufacturer of the first and only FDA-approved swallowable, gas-filled intragastric balloon system to combat obesity, has announced the grant...
Share Skyrockets on news of positive early-stage results from GEN-009 Clinical...
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinical trials of GEN-009, its neoantigen vaccine candidate....
Research in Biologics and Small Molecules aim to unravels the genetics...
Systemic lupus erythematosus (SLE) is an autoimmune disease that causes the body’s immune system to attack healthy tissue causing inflammation, photosensitivity, oral ulcers, pleuritis,...
Can Cara Therapeutics buck the trend?
Cara Therapeutics (NASDAQ: CARA) recently posted its first quarter, 2019 results. The company reported a net loss of $22.0 million, or $0.56 per basic...
Emerging Treatment Paradigms in Focal Segmental Glomerulosclerosis (FSGS)
Focal segmental glomerulosclerosis (FSGS) is a disease caused by the degeneration of glomeruli, the filtering system of the kidney’s and is caused by factors...
Research in Clonidine shows promise in the treatment of Sciatica
Sciatica also known as lumbosacral radiculopathy or radicular leg pain is a chronic pain condition that affects approximately 1 in 20 adults each year...
We are looking for talented interns to learn and help investors find valuable companies.